小剂量瑞芬太尼静脉注射用于喉罩全麻苏醒期临床分析.docVIP

小剂量瑞芬太尼静脉注射用于喉罩全麻苏醒期临床分析 　　[摘要] 目的 探讨应用小剂量瑞芬太尼静注在喉罩全麻苏醒期的临床疗效。方法 选择该院自2013年1月―2016年12月收治腹腔镜胆囊切除术行喉罩全麻的患者104例，随机分为对照组和治疗组，每组52例。对照组在术毕采取常规输液维持，不特殊处理；治疗组在术毕给予小剂量瑞芬太尼静脉注射，比较两组术毕到拔管时间、 喉罩全麻在T0、T1、T2时相的血压和心率、气道压力等变化。结果 治疗组平均拔管时间（15.3±5.6）min与对照组比较，差异有统计学意义（P0.05）。两组在T0、T1时相的血压和心率基本稳定，但治疗组在T2时相的心率（79.6±5.3）bmp与对照组（96.5±9.8）bmp比较，差异有统计学意义（P0.05）；治疗组患者在T2时相的气道压力（14.2±3.3）与对照组（17.4±3.8）比较， 差异有统计学意义（P0.05）；治疗组术后并发症发生率为13.46%，明显低于对照组（51.92%），差异有统计学意义（P0.05）。结论 在喉罩全麻苏醒期静注小剂量瑞芬太尼能够显著提高患者对喉罩的耐受性，更好地维持患者血流动力学稳定，且术后并发症发生率较小，值得推广。 　　[关键词] 瑞芬太尼；喉罩；全麻；并发症 　　[中图分类号] R68 [文献标识码] A [文章编号] 1674-0742（2017）10（b）-0140-03 　　[Abstract] Objective This paper tries to explore the clinical efficacy of low dose remifentanil in the recovery of general anesthesia of laryngeal mask. Methods 104 patients with laparoscopic cholecystectomy underwent laryngeal mask anesthesia from January 2013 to December 2016 were convenient selected and randomly divided into the control group and the treatment group， with 52 cases in each group. The control group took the conventional infusion maintenance without special treatment； the treatment group was given a small dose of remifentanil intravenous injection， and then the extubation time， laryngeal mask general anesthesia in T0， T1， T2 Time of blood pressure and heart rate， airway pressure and other changes of the two groups were compared. Results The mean extubation time was（15.3±5.6）min in the treatment group， significantly different from that in the control group（P0.05）. The blood pressure and heart rate were significantly stable in the T0 and T1， but the heart rate in the treatment group was （79.6±5.3 ）bmp in T2， different from those in the control group of （96.5±9.8）bmp （P0.05）. The airway pressure in the T2 was （14.2±3.3）， significantly higher than that the control group of （17.4±3.8）， with statistically significant difference（P0.05）. The incidence of postoperative complications was 13.46% in the treatment group， which was significantly lower than that in